ESMO Virtual

ESMO MBC Guideline - Discussing the facts

ESMO Plenary 2021

Alessandra Gennari,MD; Nadia Harbeck, MD

Update of ESMO MBC 2021 Guideline with focus on...

EMSO MBC Guideline 2021

ESMO MBC Guideline - in 100 Seconds - ENG

ESMO Plenary 2021

Nadia Harbeck, MD

TNBC: what is important? Marker first!

EMSO MBC Guideline 2021

ESMO Plenary 2021

Alessandra Gennari, MD

Luminal MBC: what is important?

EMSO MBC Guideline 2021

ESMO Plenary 2021

Alessandra Gennari, MD

HER2+: what is important? New drugs!

EMSO MBC Guideline 2021

ESMO MBC Guideline - in 100 Seconds - ITA/GER

ESMO Plenary 2021

Alessandra Gennari, MD

Carcinoma mammario metastatico - cosa è importante?

EMSO MBC Guideline 2021

ESMO Plenary 2021

Nadia Harbeck, MD

Update der ESMO Leitlinie 2021 zum metastasierten...

EMSO MBC Guideline 2021

monarchE - Discussing the facts

ESMO Plenary 2021 MonarchE

Stephen R D Johnston, MD, Nadia Harbeck, MD

monarchE with 27 months of FU: Practice changing -...

monarchE

monarchE in 100 Seconds - ENG

ESMO Plenary 2021 monarchE

Nadia Harbeck, MD

monarchE Update: Strong effect of Abemaciclib confirmed...

monarchE

ESMO Plenary 2021 MonarchE

Stephen R D Johnston, MD

monarchE Update: Clinically significant and meaningful...

monarchE

monarchE in 100 Seconds - GER

ESMO Plenary 2021 monarchE

Nadia Harbeck, MD

monarchE Update: Starker Effekt der Abemaciclib...

monarchE

KEYNOTE-522 - Discussing the facts

ESMO Plenary 2021

Javier Cortes, Diana Lüftner

CPI duration? non-pCR TNBC? Global access to therapies?...

ESMO Plenary 2021

Diana Lüftner, Nadia Harbeck, Giuseppe Curigliano

KEYNOTE-522: What's new?

ESMO Plenary 2021

Nadia Harbeck, Diana Lüftner

IMpassion031 vs. KEYNOTE-522: similar pCR, no biomarker...

ESMO Plenary 2021

Giuseppe Curigliano, Diana Lüftner

CPI patient selection: CPS vs. response

ESMO Plenary 2021

Giuseppe Curigliano, Nadia Harbeck, Diana Lüftner

What about BRCA+ TNBC? PARPi or CPI? PARPi + CPI?

ESMO Plenary 2021

Giuseppe Curigliano, Nadia Harbeck, Diana Lüftner

Will CPI change breast cancer treatment on a global...

KEYNOTE-522 - in 100 Seconds

ESMO Plenary 2021

Javier Cortes, MD

KEYNOTE-522: What is new?

ESMO Plenary 2021

Nadia Harbeck, MD

KEYNOTE-522 - a practice changer!

ESMO Plenary 2021

Giuseppe Curigliano, MD

KEYNOTE-522: First CPI in TNBC with pCR and EFS...

KEYNOTE-522 - in 100 Seconds (ESP/ITA/GER)

ESMO Plenary 2021

Giuseppe Curigliano, MD

KEYNOTE-522: Cosa è veramente importante?

ESMO Plenary 2021

Javier Cortes, MD

KEYNOTE-522: Que novedades hay?

ESMO Plenary 2021

Nadia Harbeck, MD

KEYNOTE-522 - praxis verändernd!